Questions finally answered about Nesiritide in world's largest heart failure study
Tuesday, November 16, 2010 - 14:30
in Health & Medicine
Results from the largest acute heart failure study ever conducted have resolved safety questions raised five years ago about the acute heart failure medication nesiritide (Natrecor), but more importantly illustrate the need for comprehensive, large, real world studies of investigational agents early in the course of development of new therapies, according to researchers at the Duke Clinical Research Institute.